Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.
-
Dec 13, 2018, 17:02 ET
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018
HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company...
-
Dec 13, 2018, 12:32 ET
Frost & Sullivan Publishes Q3-2018 Update On Cellect Biotechnology Ltd.
Cellect Biotechnology Ltd. is developing a technological platform, the "ApoGraft", which functionally selects stem cells from a mixed population of...
-
Dec 13, 2018, 09:16 ET
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET™ Immunotherapy Drug Candidates
Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it has licensed two TriNKET™ immunotherapy drug candidates to Celgene...
-
Dec 13, 2018, 08:59 ET
Cannabis Company SunPure Industries Enters Into First-of-Its-Kind Private-Label Contract-Manufacturing Relationship With Leading American Health and Wellness Silver Nanotech Company
SunPure Industries Ltd. ("SunPure" or the "Company"), an advanced-stage Canadian cannabis company, announced today that the Company has signed the...
-
Dec 13, 2018, 08:30 ET
Valens Signs Multi-year Cannabis Extraction Agreement with Canopy Growth
KELOWNA, BC, Dec. 13, 2018 /CNW/ - Valens GroWorks Corp. (CSE: VGW, OTC: MYMSF) (the "Company" or "Valens"), a multi-licensed, vertically...
-
Dec 11, 2018, 17:00 ET
SQI Diagnostics Reports Fourth Quarter and Fiscal 2018 Results
TORONTO, Dec. 11, 2018 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and...
-
Dec 11, 2018, 07:00 ET
Delivra publishes positive results using its platform technology for topical Advil™ (ibuprofen) and Celebrex™ (celecoxib)
TORONTO, Dec. 11, 2018 /CNW/ - Delivra Corp. (TSXV: DVA - "Delivra" or the "Company") today announced the publication of positive data from a...
-
Dec 11, 2018, 05:12 ET
Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit
GB Sciences, Inc. (OTCQB: GBLX) announced today that Dr. Andrea Small-Howard, Chief Science Officer and GB Sciences' Board Member, will present...
-
Dec 10, 2018, 11:56 ET
SQI Diagnostics' Direct-to-Consumer Partner Launches At-Home Celiac Disease Awareness Test
TORONTO, Dec. 10, 2018 /CNW/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQB: SQIDF), a life sciences and diagnostics company that develops and...
-
Dec 10, 2018, 11:30 ET
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models
MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based...
-
Dec 10, 2018, 09:00 ET
Tissue Regeneration Therapeutics and RoosterBio Inc. Form Strategic Alliance to Commercialize Umbilical Cord Tissue Cell Technology
Today Tissue Regeneration Therapeutics Inc. (TRT) and RoosterBio Inc. (RBI) announce an important strategic alliance to advance their shared goal of...
-
Dec 06, 2018, 08:00 ET
HealthSpace and Visionstate Announce Letter of Intent to Target Audit Segment of Facilities Management
VANCOUVER, Dec. 6, 2018 /CNW/ - HealthSpace Data Systems Ltd. ("HealthSpace") (CSE:HS) (Frankfurt:38H) (OTC:HDSLF) and Visionstate Corp. (TSX-V:...
-
Dec 05, 2018, 15:30 ET
Seqirus Presents Real-World Data at CIC 2018 Indicating Significantly Greater Effectiveness of Cell-Based Seasonal Influenza Vaccines Compared to Standard Influenza Vaccine Options
MONTREAL, Dec. 5, 2018 /CNW/ - Seqirus, a global leader in influenza prevention, today presented a new real-world evidence analysis at the Canadian...
-
Dec 05, 2018, 09:34 ET
Prometic to Initiate PBI-4050 Pivotal Phase 3 Clinical Trial in Alström Syndrome
- Clinical-regulatory pathway defined following recent meetings with regulatory authorities - Pivotal Phase 3 clinical trial design...
-
Dec 04, 2018, 11:30 ET
SQI Diagnostics to Extend Warrant Expiry
TORONTO, Dec. 4, 2018 /CNW/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQB: SQIDF), a life sciences and diagnostics company that develops and...
-
Dec 03, 2018, 19:21 ET
Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group
TORONTO, Dec. 3, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today confirmed that it is engaged in...
-
Dec 03, 2018, 18:46 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - UTHR
Pomerantz LLP is investigating claims on behalf of investors of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ:...
-
Dec 03, 2018, 13:25 ET
Quest PharmaTech Announces Adoption of Shareholder Rights Plan
TSX Venture: QPT EDMONTON, Dec. 3, 2018 /CNW/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a biopharmaceutical company...
-
Dec 03, 2018, 10:57 ET
Lockheed Martin Invests in FORGE Hydrocarbons' Lipid to Hydrocarbons Technology
TORONTO, Dec. 3, 2018 /CNW/ - Forge Hydrocarbons Corporation (FORGE) today announced that it has received a $4 million USD investment from Lockheed...
-
Dec 03, 2018, 09:00 ET
Vitality Joins Canadian Trade Missions to Japan and China to Expand Sales Internationally
President & CEO Participates in Trade Missions to Expand Sales into Asia Trading Symbol: VPI VANCOUVER, Dec. 3, 2018 /CNW/ - Vitality...